1. The significance of lymph node status as a prognostic factor for esophageal cancer
   Yasunori Akutsu et al, 2011, Surgery Today CrossRef
2. The number of pathologic lymph nodes involved is still a significant prognostic factor even after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma
   Yasunori Akutsu et al, 2012, Journal of Surgical Oncology CrossRef
3. Clinical Significance of 18F-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell Carcinoma
   Yoichi Hamai et al, 2019, Annals of Surgical Oncology CrossRef
4. The Prognostic Value of a Pathologic Complete Response After Neoadjuvant Therapy for Digestive Cancer: Systematic Review and Meta-Analysis of 21 Studies
   Tao Wan et al, 2019, Annals of Surgical Oncology CrossRef
5. Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis
   Eliza Hagens et al, 2022, Diseases of the Esophagus CrossRef
6. Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
   Yoichi Hamai et al, 2018, World Journal of Surgery CrossRef
7. Positron emission tomography complete metabolic response as a favorable prognostic predictor in esophageal cancer following neoadjuvant chemotherapy with docetaxel/cisplatin/5-fluorouracil
   Kosuke Suzuki et al, 2021, World Journal of Clinical Oncology CrossRef
8. Clinicopathological factors predicting R0 resection and long-term survival after esophagectomy in patients with T4 esophageal cancer undergoing induction chemotherapy or chemoradiotherapy
   Hiroyuki Karimata et al, 2015, Surgery Today CrossRef
9. A phase I/II clinical trial of preoperative short‐course carbon‐ion radiotherapy for patients with squamous cell carcinoma of the esophagus
   Yasunori Akutsu et al, 2012, Journal of Surgical Oncology CrossRef
10. Association between prognosis and lymph node status using 18F‐fluorodeoxyglucose‐positron emission tomography in esophageal squamous cell carcinoma treated with esophagectomy post‐neoadjuvant chemotherapy
    Manato Ohsawa et al, 2024, World Journal of Surgery CrossRef
11. Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies
    G. Tomasello et al, 2017, European Journal of Surgical Oncology CrossRef